• Je něco špatně v tomto záznamu ?

A global perspective on the status of clinical metabolomics in laboratory medicine - a survey by the IFCC metabolomics working group

E. Fux, M. Lenski, AK. Bendt, JD. Otvos, J. Ivanisevic, S. De Bruyne, E. Cavalier, D. Friedecký

. 2024 ; 62 (10) : 1950-1961. [pub] 20240626

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018864

OBJECTIVES: Metabolomics aims for comprehensive characterization and measurement of small molecule metabolites (<1700 Da) in complex biological matrices. This study sought to assess the current understanding and usage of metabolomics in laboratory medicine globally and evaluate the perception of its promise and future implementation. METHODS: A survey was conducted by the IFCC metabolomics working group that queried 400 professionals from 79 countries. Participants provided insights into their experience levels, knowledge, and usage of metabolomics approaches, along with detailing the applications and methodologies employed. RESULTS: Findings revealed a varying level of experience among respondents, with varying degrees of familiarity and utilization of metabolomics techniques. Targeted approaches dominated the field, particularly liquid chromatography coupled to a triple quadrupole mass spectrometer, with untargeted methods also receiving significant usage. Applications spanned clinical research, epidemiological studies, clinical diagnostics, patient monitoring, and prognostics across various medical domains, including metabolic diseases, endocrinology, oncology, cardiometabolic risk, neurodegeneration and clinical toxicology. CONCLUSIONS: Despite optimism for the future of clinical metabolomics, challenges such as technical complexity, standardization issues, and financial constraints remain significant hurdles. The study underscores the promising yet intricate landscape of metabolomics in clinical practice, emphasizing the need for continued efforts to overcome barriers and realize its full potential in patient care and precision medicine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018864
003      
CZ-PrNML
005      
20241024111127.0
007      
ta
008      
241015s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/cclm-2024-0550 $2 doi
035    __
$a (PubMed)38915248
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Fux, Elie $u Roche Diagnostics GmbH, Penzberg, Germany
245    12
$a A global perspective on the status of clinical metabolomics in laboratory medicine - a survey by the IFCC metabolomics working group / $c E. Fux, M. Lenski, AK. Bendt, JD. Otvos, J. Ivanisevic, S. De Bruyne, E. Cavalier, D. Friedecký
520    9_
$a OBJECTIVES: Metabolomics aims for comprehensive characterization and measurement of small molecule metabolites (<1700 Da) in complex biological matrices. This study sought to assess the current understanding and usage of metabolomics in laboratory medicine globally and evaluate the perception of its promise and future implementation. METHODS: A survey was conducted by the IFCC metabolomics working group that queried 400 professionals from 79 countries. Participants provided insights into their experience levels, knowledge, and usage of metabolomics approaches, along with detailing the applications and methodologies employed. RESULTS: Findings revealed a varying level of experience among respondents, with varying degrees of familiarity and utilization of metabolomics techniques. Targeted approaches dominated the field, particularly liquid chromatography coupled to a triple quadrupole mass spectrometer, with untargeted methods also receiving significant usage. Applications spanned clinical research, epidemiological studies, clinical diagnostics, patient monitoring, and prognostics across various medical domains, including metabolic diseases, endocrinology, oncology, cardiometabolic risk, neurodegeneration and clinical toxicology. CONCLUSIONS: Despite optimism for the future of clinical metabolomics, challenges such as technical complexity, standardization issues, and financial constraints remain significant hurdles. The study underscores the promising yet intricate landscape of metabolomics in clinical practice, emphasizing the need for continued efforts to overcome barriers and realize its full potential in patient care and precision medicine.
650    12
$a metabolomika $x metody $7 D055432
650    _2
$a lidé $7 D006801
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a chromatografie kapalinová $7 D002853
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lenski, Marie $u ULR 4483, IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, Univ. Lille, Institut Pasteur de Lille et Unité Fonctionnelle de Toxicologie, CHU Lille, Lille, France
700    1_
$a Bendt, Anne K $u Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Singapore $1 https://orcid.org/0000000181986104
700    1_
$a Otvos, James D $u Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Ivanisevic, Julijana $u Metabolomics Unit, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
700    1_
$a De Bruyne, Sander $u Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium
700    1_
$a Cavalier, Etienne $u Department of Clinical Chemistry, CIRM, University of Liège, CHU de Liège, Liège, Belgium $1 https://orcid.org/0000000309472226
700    1_
$a Friedecký, David $u Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czechia $u Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000234489073 $7 xx0142900
773    0_
$w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 62, č. 10 (2024), s. 1950-1961
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38915248 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111121 $b ABA008
999    __
$a ok $b bmc $g 2201620 $s 1230837
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 62 $c 10 $d 1950-1961 $e 20240626 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace